DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9wz3p9/male)
has announced the addition of the “Male
Infertility-Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2016” report to their offering.
This report, Male Infertility-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2016, provides comprehensive insights about
the marketed drugs, drug sales, Phase III pipeline drugs and their API
Manufacturers across the globe.
The Report provides the historical and forecasted sales of the drugs
till 2018. The Report gives insights into patents providing the patent
protection data and marketing exclusivity of all the drugs across the
Key Topics Covered:
A snapshot of the global Market and Phase III therapeutics scenario
for Male Infertility.
A review of the marketed products under prescription for Male
Infertility, regulatory information and marketing status.
Coverage of global patent coverage and detailed commentaries on the US
Graphical representation of investigational products for patent expiry
and market exclusivities across the globe.
Coverage of API Manufacturers for Male Infertility drugs in the United
States, Europe and Asian Regions with location details.
Benefits of this Report:
Evaluate the marketing status and exclusivity details of Male
Infertility key products to exploit opportunities for generic drug
Identify and understand important and diverse types of therapeutics
under Phase III development for Male Infertility.
Design effective counter-strategies to gain competitive advantage by
identifying the key patent expiry details and exclusivity with respect
to Male Infertility.
API intelligence over marketed drugs forMale Infertility and gaining
primary intelligence over active ingredients manufacturers across the
1. Indication Overview
2. Market Drugs Landscape
3. Global API Manufacturers Assessment
4. Phase III Drugs Landscape
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Male Infertility
7. Phase III Drugs for Male Infertility
8. Discontinued Drugs for Male Infertility
11. Consulting Services
12. Contact Us
For more information visit http://www.researchandmarkets.com/research/9wz3p9/male
Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
and Medical Devices, Pharmaceuticals